Long R G, Meinhard E, Skinner R K, Varghese Z, Wills M R, Sherlock S
Gut. 1978 Feb;19(2):85-90. doi: 10.1136/gut.19.2.85.
Twenty of 32 patients with either chronic cholestatic or hepatocellular liver disease had bone pain or recent fractures. On bone biopsy five patients had normal bone, 15 had osteomalacia, five had osteoporosis, and seven had a combination of osteomalacia and osteoporosis. In the presence of osteoporosis, osteomalacia was minimal or absent. There was no biochemical, radiological, or histological evidence of excess parathyroid activity. No significant correlations were demonstrated between the plasma and urinary biochemical findings and the presence of either osteoporosis or osteomalacia and bone biopsy was essential for correct diagnosis. There was no statistical relationship between low serum 25-hydroxy vitamin D values and the presence of osteomalacia. Bone disease was not prevented by regular intramuscular vitamin D2, although biochemical changes were improved. Drugs such as corticosteroids and cholestyramine may be important aetiological factors in hepatic osteodystrophy.
32例慢性胆汁淤积性或肝细胞性肝病患者中,有20例出现骨痛或近期骨折。骨活检显示,5例患者骨正常,15例有骨软化症,5例有骨质疏松症,7例同时存在骨软化症和骨质疏松症。在存在骨质疏松症的情况下,骨软化症程度较轻或不存在。没有生化、放射学或组织学证据表明甲状旁腺活动过度。血浆和尿液生化检查结果与骨质疏松症或骨软化症的存在之间没有显著相关性,骨活检对于正确诊断至关重要。低血清25-羟维生素D值与骨软化症的存在之间没有统计学关系。尽管生化指标有所改善,但定期肌肉注射维生素D2并不能预防骨病。皮质类固醇和消胆胺等药物可能是肝性骨营养不良的重要病因。